Superworth

SkinHealth Systems price to free cash flow SKIN

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Nov 2, 2026
3.2×
3-year median
6.6×
Against its 3-year history
12th
percentile: 0 is its lowest day, 100 its highest
3-year range
2.6× to 176×
Peer median
12.0×

SkinHealth Systems' price to free cash flow is 3.2× as of Nov 2, 2026.

That is below its 3-year median of 6.6×, lower than on 88% of days in the last 3 years.

Over that time it ranged from 2.6× in May 2026 to 176× in Aug 2024.

The median for 8 medical instruments and supplies stocks of a similar size is 12.0×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far3.2×2.6×5.1×
20254.8×4.2×10.8×
2024160×12.0×176×
202324.4×17.7×25.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest SkinHealth Systems' size, closest first, today.

CompanyPrice to free cash flow
SKINSkinHealth Systems3.2×
APTAlpha Pro Tech9.6×
KEQUKewaunee Scientific8.9×
NEPHNephrosn/m
PDEXPro DEX17.3×
UTMDUtah Medical Products19.6×
INFUInfuSystem12.0×
EMBCEmbecta2.1×
TCMDTactile Systems Technology19.3×
Peer median12.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on SkinHealth Systems

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.